Chinese Medicine Regulatory Office

 Home > Useful Information > Government Chinese Medicines Testing Institute > Training & International Collaboration > Mainland and International Collaboration > 2025

Training & International Collaboration


Mainland and International Collaboration


The Government Chinese Medicines Testing Institute (GCMTI) has been actively organising and participating in various exchange activities to promote co-operation and establish close connections with institutions in the Mainland and overseas, at the same time, to promote harmonisation of reference standards and testing methods for Chinese medicines.

Highlights
2025
March
  • The World Health Organization Regional Director for the Western Pacific, Dr Saia Ma'u Piukala visited the GCMTI.
    Press Release

May
  • Attended the 22th Standing Committee Meeting and the 10th International Symposium of the Western Pacific Regional Forum for the Harmonization of Herbal Medicines (FHH) held in Vietnam. Reported the latest developments in the regulation and quality standards of Chinese medicines in Hong Kong.

June
  • The Chinese Medicine Regulatory Office of the Department of Health (DH) signed a Co-operation Arrangement with the Guangxi Botanical Garden of Medicinal Plants, a subsidiary organisation of the Administration of Traditional Chinese Medicine of Guangxi Zhuang Autonomous Region. This arrangement aims to promote exchange and collaboration in medicinal plant cultivation techniques and germplasm resource sharing, as well as the promotion of medicinal plants, jointly advancing the modernisation and internationalisation of Chinese medicines.
    Press Release

July
  • The DH signed a Co-operation Arrangement with the Guangzhou Municipal Market Regulatory Administration to deepen exchange and co-operation in the regulation of drugs and medical devices between Guangzhou and the Hong Kong Special Administrative Region, and further strengthen co-operation in the testing of Chinese medicines between the Guangzhou Institute for Drug Control and the GCMTI, driving the high-quality development of Chinese medicines in the Guangdong-Hong Kong-Macao Greater Bay Area.
    Press Release

October
  • Attended the 16th Annual Meeting of the World Health Organization (WHO) International Regulatory Cooperation for Herbal Medicines held in Indonesia. Reported on the latest developments in the regulatory framework, quality control and standards for Chinese medicines in Hong Kong.